| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 08/03/2006 | CA2595848A1 Erastin and erastin binding proteins, and uses thereof |
| 08/03/2006 | CA2595218A1 Indole derivatives having inhibitory activity against sodium-dependent glucose transporter |
| 08/02/2006 | EP1686127A1 New heterocyclylmethyl-substituted pyrazole derivatives and their use for treating cardiovascular diseases |
| 08/02/2006 | EP1685128A1 Process for preparing benzimidazole thiophenes |
| 08/02/2006 | EP1685119A1 N-acylsulfonamide apoptosis promoters |
| 08/02/2006 | EP1685116A1 Quinazoline derivatives |
| 08/02/2006 | EP1685113A1 Substituted pyrazoles as ppar agonists |
| 08/02/2006 | EP1685111A1 Substituted nicotinoylcarbamates as pesticides |
| 08/02/2006 | EP1685109A2 Amide compounds as ion channel ligands and uses thereof |
| 08/02/2006 | EP1685108A1 1,4-dihydropyridine compounds, pharmaceutical compositions, and methods for the treatment of cardiovascular disease |
| 08/02/2006 | EP1685107A1 1,4-dihydropyridine compounds, pharmaceutical compositions, and methods for the treatment of cardiovascular disease |
| 08/02/2006 | EP1685101A1 N-acylated-3-(benzoyl)-pyrrolidines as 11-beta-hsd1 inhibitors useful for the treatment of metabolic disorders. |
| 08/02/2006 | EP1685100A1 Novel 1, 3-disubstituted azetidine derivatives for use as 5ht2a receptor ligands |
| 08/02/2006 | EP1684757A1 Substituted piperidines for the treatment of metabolic syndrome |
| 08/02/2006 | EP1684745A2 Hepatitis c virus inhibitors |
| 08/02/2006 | EP1684744A2 Pyrrolidine and piperidine derivatives as factor xa inhibitors |
| 08/02/2006 | EP1358177B1 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance |
| 08/02/2006 | EP1073637B1 3-(amino- or aminoalkyl)pyridinone derivatives and their use for the treatment of hiv related diseases |
| 08/02/2006 | EP0986551B1 Sulfonamide derivatives, their production and use |
| 08/02/2006 | EP0970935B1 Method of separating optical isomers |
| 08/02/2006 | CN1812985A Mch antagonists for the treatment of obesity |
| 08/02/2006 | CN1812984A Benzofuranyl-and benzothienyl-piperazinyl quinolines as 5-serotonin reuptake inhibitors |
| 08/02/2006 | CN1812981A Heteroaryloxy nitrogenous saturated heterocyclic derivative |
| 08/02/2006 | CN1812973A Indazole compounds useful as protein kinase inhibitors |
| 08/02/2006 | CN1812787A 8-(3-biaryl)phenylquinoline phosphodiesterase-4-inhibitors |
| 08/02/2006 | CN1267431C Substituted quinazoline derivatives and their use as inhibitors |
| 08/02/2006 | CN1267430C Triazole compounds with dopamine -D3-receptor affinity |
| 08/02/2006 | CN1267424C Piperazinylpyrazine compounds as agonist or antagonist of 5-hydroxytryptamine 5HT-2 receptor |
| 08/02/2006 | CN1267419C Trifluoromethylpyrrole carboxamides and trifluoromethylpyrrolethioamides as fungicides |
| 08/02/2006 | CN1267418C Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics |
| 08/01/2006 | US7084168 Indoline derivatives |
| 08/01/2006 | US7084164 Triazole derivative |
| 08/01/2006 | US7084159 Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases |
| 08/01/2006 | US7084158 Substituted propargylamines |
| 08/01/2006 | US7084155 Chemokine receptor binding heterocyclic compounds |
| 08/01/2006 | US7084143 N-(indolecarbonyl) piperazine derivatives |
| 08/01/2006 | US7084142 Anticoagulants; 2-[1S-(4-(ethoxycarbonyl)piperazin-1-yl)carbonyl-3-carboxypropyl]aminocarbonyl-4-(2-methylthiazol-4-yl)methoxyquinoline; antithrombotic agents in the treatment and prevention of thrombosis |
| 08/01/2006 | US7084141 Therapeutic treatment of diabetes with a 4-[piperazine-1-yl]-1,2-dihydro-quinolines; treating tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis |
| 08/01/2006 | US7084139 Cardiovascular disorders; anticoagulants; antitumor, anticancer agents; Alzheimer's disease; Parkinson's disease |
| 08/01/2006 | US7083928 Detection of negatively charged polymers using water-soluble, cationic, polythiophene derivatives |
| 08/01/2006 | CA2276945C Tricyclic-substituted pyrazolyl benzenesulfonamides and pharmaceutical compositions thereof |
| 08/01/2006 | CA2236851C Substituted vinylpyridine derivatives and drugs containing the same |
| 08/01/2006 | CA2189456C Substituted aromatic thiocarboxylic acid amides and their use as herbicides |
| 07/27/2006 | WO2006078753A1 N-substituted heterocyclic sulfonamides |
| 07/27/2006 | WO2006078287A2 Pde4b inhibitors and uses therefor |
| 07/27/2006 | WO2006078283A2 Quinoxaline inhibitors of hedgehog signalling |
| 07/27/2006 | WO2006077851A1 Quinolone derivative and salt thereof |
| 07/27/2006 | WO2006077497A1 Crystalline forms cis-5-fluoro-n-[4-(2-hydroxy-4-methylbenzamido) cyclohexyl]-2-(tetrahydrothiopyran-a-yloxy) nicotinamide |
| 07/27/2006 | WO2006077320A1 N-[(4,5-diphenyl-2-thienyl)methyl]sulfonamide derivatives, preparation thereof and their therapeutic application |
| 07/27/2006 | WO2006026033A3 Novel chalcogenoxanthylium dyes for purging blood pathogens and for photodynamic therapy |
| 07/27/2006 | US20060167275 Isomerization; crystallization |
| 07/27/2006 | US20060167251 CCR9 inhibitors and methods of use thereof |
| 07/27/2006 | US20060167247 Urea inhibitors of MAP kinases |
| 07/27/2006 | US20060167217 Coating composition, coating film made of same, and optical article |
| 07/27/2006 | US20060167079 For treating thrombosis and factor xa-related cardiovascular and neurodegenerative diseases; (1E)-N-(1-{4-[2-(1-Azetidinylmethyl)-1H-imidazol-1-yl]-2-fluorophenyl}-2-oxo-3-pyrrolidinyl)-2-(5-chloro-2-thienyl)-1-propene-1-sulfonamide for example |
| 07/27/2006 | US20060167065 Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease |
| 07/27/2006 | US20060167055 Non-nucleoside reverse transcriptase inhibitors |
| 07/27/2006 | US20060167052 Piperidine derivative, process for producing the same, and use |
| 07/27/2006 | US20060167047 Tetrahydorquinoline derivatives and their use as fsh receptor modulators |
| 07/27/2006 | US20060167044 Piperidine derivatives and their use as anti-inflammatory agents |
| 07/27/2006 | US20060167043 Isoquinoline derivatives having kinasae inhibitory activity and drugs containing the same |
| 07/27/2006 | US20060167008 Substituted 1,4,-di-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists |
| 07/27/2006 | US20060167004 4(Phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders |
| 07/27/2006 | US20060167001 Pyridazinone-derivatives as pde4 inhibitors |
| 07/27/2006 | US20060166991 Pyridine carboxamide derivatives and their use as pesticides |
| 07/27/2006 | US20060166988 Novel compounds |
| 07/27/2006 | US20060166985 Pyrrolydin-2-one derivatives as inhibitors of thrombin and factor xa |
| 07/27/2006 | US20060166961 Cell adhesion inhibitors |
| 07/27/2006 | US20060166894 Ace-inhibitors having antioxidant and no-donor activity |
| 07/27/2006 | CA2595173A1 N-substituted heterocyclic sulfonamides |
| 07/27/2006 | CA2595045A1 N-[(4,5-diphenyl-2-thienyl)methyl]sulfonamide derivatives, preparation thereof and their therapeutic application |
| 07/27/2006 | CA2594785A1 Crystalline forms cis-5-fluoro-n-[4-(2-hydroxy-4-methylbenzamido) cyclohexyl]-2-(tetrahydrothiopyran-a-yloxy) nicotinamide |
| 07/27/2006 | CA2565965A1 Pde4b inhibitors and uses therefor |
| 07/26/2006 | EP1683804A2 Platinum complex and luminescent element |
| 07/26/2006 | EP1683795A1 Crystalline forms of cis-5-fluoro-N-¬4-(2-hydroxy-4-methylbenzamido)cyclohexyl|-2-(tetrahydrothiopyran-4-yloxy)nicotinamide |
| 07/26/2006 | EP1682538A1 Biaryl linked hydroxamates: preparation and pharmaceutical applications |
| 07/26/2006 | EP1682537A1 Modulators of cellular adhesion |
| 07/26/2006 | EP1682529A2 Methods for synthesizing quinolinone compounds |
| 07/26/2006 | EP1682517A1 Process for the synthesis of imidazoles |
| 07/26/2006 | EP1682511A2 Methods and compositions for selectin inhibition |
| 07/26/2006 | EP1682510A2 Methods and compositions for selectin inhibition |
| 07/26/2006 | EP1682509A1 Pyridine carboxylic acid derivatives as glucokinase modulators |
| 07/26/2006 | EP1682139A1 Preparation of pharmaceutical salts of 1, 4 - bipiperidine |
| 07/26/2006 | EP1682126A1 Substituted benzazoles and use thereof as inhibitors of raf kinase |
| 07/26/2006 | EP1682117A1 2-azetidinones as anti-hypercholesterolemic agents |
| 07/26/2006 | CN1809559A Pyrazole derivatives as phosphodiesterase 4 inhibitors |
| 07/26/2006 | CN1809552A Cannabinoid derivatives, methods of making, and use thereof |
| 07/26/2006 | CN1809540A Inhibitors of Akt activity |
| 07/26/2006 | CN1809538A Cis-2,4,5-triaryl-imidazolines |
| 07/26/2006 | CN1809349A 5-oxo and 5-thio derivatives of 5h-indeno'1,2-bipyridine with adenosine A2A receptor binding and phosphodiesterase inhibiting activity for the treatment of neurodegenerative disorders and inflammation |
| 07/26/2006 | CN1807428A Condensed ring unit terminated oligomerized thiophen analog high mobility organic semi-conducting material and its uses |
| 07/26/2006 | CN1807426A Heteroaryl urea neuropeptide y y5 receptor antagonists |
| 07/26/2006 | CN1807421A High optical activity chiral phthalide analog compound and synthesis method |
| 07/26/2006 | CN1266138C Gyrase imhibitors and uses thereof |
| 07/26/2006 | CN1266112C Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 07/26/2006 | CN1266095C Process for the production of 1,2-dichloroethane by direct chlorination |
| 07/25/2006 | US7081473 Glucose dependent-insulinotropic polypeptide, or gastric inhibitory polypeptide (GIP) inhibitors; p-methylidene hydrizide phenols |
| 07/25/2006 | US7081470 Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |
| 07/25/2006 | US7081454 Anticancer agents |
| 07/25/2006 | US7081279 Alkenyl compound having a negative Δε value, liquid crystal composition, and liquid crystal display device |